Related Experiment Videos
Cardiac transplantation: a review
1Transplant Unit, Papworth Hospital, Cambridge, England, UK.
Insights
Cardiac transplantation is a vital treatment for end-stage heart failure, offering improved survival rates. Key challenges include managing rejection, infection, and graft coronary disease to enhance long-term outcomes.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- Cardiac transplantation is an established therapy for end-stage heart failure.
- Current 5-year and 10-year survival rates are 67% and 52%, respectively.
- Graft coronary occlusive disease, rejection, and infection remain significant challenges.
Purpose of the Study:
- To review donor and recipient selection criteria for cardiac transplantation.
- To summarize current and emerging immunosuppressive strategies.
- To discuss major complications including infection, rejection, nephrotoxicity, and graft coronary occlusive disease.
Main Methods:
- Literature review of cardiac transplantation.
- Analysis of donor and recipient selection criteria.
- Overview of immunosuppressive protocols and agents.
- Summary of post-transplant complications.
Main Results:
- Cardiac transplantation survival rates are improving but limited by specific complications.
- Effective immunosuppression is crucial for preventing rejection.
- Infection and graft coronary occlusive disease significantly impact long-term survival.
Conclusions:
- Cardiac transplantation is a definitive treatment for end-stage heart failure.
- Ongoing research focuses on optimizing immunosuppression and managing complications.
- Further advancements are needed to improve long-term graft survival and patient outcomes.
Abstract:
Cardiac transplantation is no longer an experimental procedure, but rather a definitive therapeutic option for patients with end-stage cardiac failure. The current 5-year and 10-year survival rates following cardiac transplantation are 67% and 52%, respectively. Rejection and infection still result in significant morbidity and mortality, and the development of graft coronary occlusive disease limits even longer-term survival. This review summarises donor and recipient selection criteria, the operative procedure, the current immunosuppressive protocols, as well as newer immunosuppressive agents and the complications of cardiac transplantation, namely infection, rejection, nephrotoxicity and graft coronary occlusive disease.